Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Current-Liabilities" stands at 32.00 Billion United States Dollars as of 09/30/2025, the highest value since 12/31/2023.
As of the end of Novartis AG's third quarter, the item "Total Current Liabilities" stands at 32.00 Billion USD. This represents an increase of 0.9 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.75 percent compared to the value the year prior.
The 1 year change in percent is 13.75.
The 3 year change in percent is 13.64.
The 5 year change in percent is 0.5088.
The 10 year change in percent is 13.64.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Current Liabilities | 280,205,508,085.11 |